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Background: The increasing incidence and prevalence of chronic kidney disease is an important challenge for
health systems around the world. Access for care of the disease in Ethiopia is extremely limited. The main purpose
of the study was to investigate survival pattern and assess risk factors for poor outcome of patients on maintenance
hemodialysis for end stage renal disease in Ethiopia.
Methods: Medical records of patients on maintenance hemodialysis for end stage renal disease at Saint Gabriel
General Hospital between 2002 and 2010 were reviewed. The data was collected by complete review of patient’s
clinical data. Descriptive statistics was used for most variables and Chi-square test, where necessary, was used to
test the association among various variables. Kaplan-Meier survival analysis was done to assess both short and long
term survival. P-values of < 0.05 were considered as statistically significant.
Results: A total of 190 patients were registered for hemodialysis at the hospital 91 of which were included in the
final assessment. Mean age at dialysis initiation was 58 ± 15 years. Fifty-five (60.4%) of the patients had prior history
of diabetes. Almost all of them had serum creatinine of > 5mg/dl and some degree of anemia at dialysis initiation.
Forty-one (45.1%) deaths occurred during dialysis treatment and 21 (23.1%) of patients died within the first 90 days
of starting dialysis. Only 42.1% of them survived longer than a year. The frequently registered causes of death were
septicemia (34.1%) and cardiovascular diseases (29.3%). Use of catheter as vascular access was associated with
decreased short term and long term survival.
Conclusion: Dialysis as treatment modality is extremely scarce in Ethiopia and affordable to only the rich. Survival
pattern in those on the treatment is less satisfactory and short of usual standards in the developed world and
needs further investigation. We thus recommend a large scale analysis of national dialysis registry at all dialysis
centers in the country.Background
Chronic kidney disease (CKD) is an important challenge
for health systems around the world [1] consuming a
huge proportion of health care finances [2,3]. It is even
more significant for developing countries [1,4] which
now face the double burden of infectious diseases and
growing problems of non-communicable diseases such
as obesity, diabetes and hypertension [5]. About 85% of
the world populations live in less developed part of the
world where CKD prevention programs are either
rudimentary or virtually nonexistent [3]. Morbidities and* Correspondence: esakgd@gmail.com
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reproduction in any medium, provided the ormortalities emanating from CKD in these countries are
immense and related to limited access for treatment
options [2].
Renal replacement therapy (RRT) is the mainstay of
care for patients with end stage renal disease (ESRD).
Dialysis as an option of RRT prolongs survival, reduces
morbidities and improves quality of life. However, despite
many technical advances, morbidities and mortalities of
patients on dialysis remain unacceptably high and their
quality of life is often poor [6]. Common independent
predictors of survival are age, race, serum albumin at the
start of dialysis, activity level at the start of dialysis, and
presence of certain comorbidities such as heart failure and
cancer [7].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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most countries in sub-Saharan Africa. The region contrib-
utes to less than 5% of patients on RRT worldwide [5,8-10].
Dialysis and transplant programs in this part of the world
are dependent on the availability of external funding and
donors. As a result, only less than 5% of patients with
diagnosed ESRD are able to get treatment for longer than 3
months [2].
For many years the magnitude of ESRD in Ethiopia
has not been studied. The use of dialysis in the country
as a treatment strategy for ESRD dates less than a
decade. In addition, access for dialysis is limited and is a
highly unaffordable for the general public. Each dialysis
session costs about $100 (1700 Birr) excluding the costs
for other supportive cares. Because of the low socio-
economic status, dialysis is thus considered as luxury
care in the country. There is currently no dialysis center
in Public hospitals in Ethiopia with a population surpass-
ing 85 million. In addition, there is no national strategy for
prevention and care of patients with CKD.
The aim of this study was to investigate survival patterns
of patients on maintenance hemodialysis for end stage
renal disease and assess factors related to poor outcomes.
Methods
Setting
This is a retrospective analysis of patients’ clinical data
on maintenance hemodialysis for ESRD at St Gabriel
General Hospital between February 2002 and August
2010. The hospital is located in Addis Ababa, Ethiopia.
It is the first private Hospital established in 1995 and
one of the three dialysis centers in the country. By the
time the study was conducted, the center had three dia-
lysis machines operated by two dialysis nurses, a general
practitioner with short term training on dialysis and one
nephrologist.
Participants
Patients on maintenance hemodialysis for ESRD at the
hospital between February 2002 and August 2010.
Inclusion criteria
All adult patients (18 years and older) who were on
maintenance hemodialysis for ESRD during the specified
period were included in the study.
Exclusion criteria
1. Patients who started on hemodialysis for acute renal
failure.
2. Incomplete medical records
3. Patients on transient hemodialysis (patients from
abroad who took maintenance dialysis at the Centre
for short period of time)Selection of participants
Dialysis registration book was reviewed to identify pa-
tients who were eligible for the study. The charts of all
eligible patients were then identified for review.
Data collection
The data was collected by using pretested structured
questionnaire that consisted of characteristics related to
demographic profiles, causes and risk factors of CKD,
clinical conditions of patients at initiation and last session
of dialysis and treatments given. These were collected by
reviewing patients’ medical records and dialysis registra-
tion book.
Data quality control
Data collectors were trained and supervised during data
collection. Charts were coded to avoid repetition of re-
cording and findings were cross-checked with dialysis
registration book. The collected data were also checked
for completeness and internal consistency.
Data processing, analysis and interpretation
The data were coded, cleaned, entered and analyzed with
the help of SPSS version 16. Multivariate analysis and
other descriptive statistics were used for most variables
and Chi-square test, where necessary, was used to test
the association among various variables. Kaplan- Meier
survival analysis was used to assess the time to death
after initiation of dialysis treatment. P-values of < 0.05
were considered as statistically significant.
Operational definitions
Patient outcome in this study refers to condition at the
final session of dialysis – dead or alive. Only those deaths
without any other plausible explanations (in the absence
of any other immediate condition independent of ESRD
like trauma) were recorded as relevant. Deaths in the first
ninety days of initiation of dialysis were regarded as early
mortality.
Ethical considerations
Ethical approval was obtained from Jimma University
Ethical review board. The information obtained from the
chart will remain confidential indefinitely.
Result
A total of 190 patients were registered for hemodialysis
at the hospital between 2002 and 2010. Only 91 patients
were included for final outcome analysis; the rest were
excluded for different reasons.
Baseline characteristics at initiation of dialysis
Table 1 summarizes background characteristics of 91
patients that were included in the study. The mean age
Table 2 Treatment modalities for 91 patients on
maintenance hemodialysis for end stage renal
disease in Ethiopia
Characteristics N (%)
Frequency of dialysis sessions/week
Once 11(12.1)
Twice 51(56.0)
Three times 29 (31.9)
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years). Only 5.5% of them were from outside Addis Ababa
(Table 1).
Fifty-five (60.4%) of the patients had prior history of
diabetes, 5 of which had both diabetes and hypertension
(Table 1).
The mean serum creatinine at dialysis initiation was
10.7 ± 3.4.mg/dl. All but one patient had creatinine > 5mg/
dl. Over half of them had creatinine > 10mg/dl. Virtually
all of them had some degree of anemia at initiation of
dialysis. The mean hematocrit was 29.5 ± 4.5% (range
18.8% to 40%).
Arteriovenous fistula and catheter were the predomin-
ant vascular accesses used for hemodialysis at the hospital
(Table 1).
Treatment modalities
Most of the patients (87.9%) had at least two sessions of
dialysis a week. The duration of each session ranged
between 3 to 4 hours (Table 2). On average, patients
took maintenance hemodialysis for a median of 132
days. Two patients took only one session of dialysis and
died immediately. Only one patient survived longer than
6 years taking a total of 742 dialysis sessions.Table 1 Background characteristics of 91 patients on
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CKD Chronic Kidney disease.About 74% of patients were given some forms of med-
ications for complications of CKD, 58.3% were given
erythropoietin, 43% of which were given regularly. Fifty-
nine (64.8%) of them have been given blood transfusion
at least once during their time on dialysis (Table 2).
Comorbidities
Some forms of comorbid conditions occurred in 47
(51.6%) of the patients. The most common comorbidity
identified was cardiovascular disease (CVD) which was
recorded in 29.7% of the cases. Five of CVD cases were
acute myocardial infarction. Thirteen (14.3%) of them de-
veloped sepsis sometime during their course. Intradialytic
hypotension occurred in 38.5% of patients at least once
during the period on dialysis.
Outcome assessment
The mean creatinine and hematocrit levels at the last
session of dialysis were 8.7 ± 3.1mg/dl and 29.8 ± 5%
respectively. A paired t-test showed that serum creatin-
ine at the last session of dialysis decreased by 1.97mg/dl
from the value at initiation of dialysis (p < 0.0001). The
blood urea nitrogen (BUN) also significantly dropped
from pre-dialysis level of 118.9 ± 45.0mg/dl to 92.8 ±
47.5mg/dl at the last session (p < 0.0001). However, there
was no significant change in hematocrit level.
Forty-one (45%) deaths occurred during dialysis treat-
ment; 21 of the deaths occurred within the first 90 days
of starting dialysis. Thirty-six deaths occurred at the
hospital and the remaining 5 occurred at home. Survival
at three month and one year was 61.5% and 42.1%
respectively. The frequently registered causes of death
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(29.3%) (Table 3)
There was no significant mortality difference between
age groups, sex, serum creatinine and hematocrit levels
at dialysis initiation. However, mortality markedly varied
among the type of vascular access used with the highest
observed among those using catheter (p < 0.0001).
Kaplan – Meier survival analysis also showed that only
the type of vascular access used and erythropoietin treat-
ment significantly affected both short-term and long
term survival patterns. The median survival in patient
using catheter, fistula and vascular graft was 2.8, 27.2 and
39 months respectively (P < 0.0001). No patient using
catheter survived longer than 21 months. Similarly, twelve
month survival in patients who were given EPO was
53.2% as compared to 26.1% in those who were never
given it (P = 0.002) (Figure 1).
The age and sex adjusted HR for catheter use was
8.399 (95% CI, 1.948 to 36.216; p = 0.004). For erythro-
poietin treatment, this was found to be 0.320 (95% CI,
0.165 to 0.623; p = .001).
Discussion
Renal replacement therapy is an extremely scare treat-
ment modality in Ethiopia and accessible to only few
wealthy urban dwellers. Long term survival in those
undergoing dialysis is very low and can be attributable
to various medical conditions. Findings in this study are
from one dialysis center in Ethiopia and can be used as a
preliminary data for future studies and help improve
care of such patients.
Most of the patients (60.4%) with ESRD at the hospital
had prior diagnosis of diabetes mellitus. Even though
this does not guarantee diabetes as the culprit, it is of
paramount clinical importance as far as the disease bur-
den is concerned. Only 17.6% of them were diagnosed
with glomerulonephritis unlike other studies in Africa
where it was found to be the commonest cause of CKDTable 3 Outcome of 91 patients on maintenance hemodialysi











‡10 patients discontinued dialysis, 9 referred for renal transplant abroad, 10 left the[8,11]. As there was no routine renal biopsy and other
necessary investigations for diagnosis of renal diseases,
the real causes of ESRD in this setting cannot be easily
stated. In addition, findings from this study can never be
used as a representative data for the country as most of
the participants were from Addis Ababa where the living
standard is better and hygiene is good.
Diagnosis of CKD was based on clinical ground only
like elsewhere in Africa [11]. GFR was not done for most
of the patients at initiation of dialysis and the criteria to
start dialysis were based mainly on patients’ clinical
conditions such as uremic symptoms and fluid overload
intractable to medical treatments. However, the mean
serum creatinine of 10.7mg/dl at initiation of dialysis
was comparable with findings from different countries
around the world [12,13].
The median survival was 263 days with 62.1% of
patients surviving their 90th day after starting dialysis.
This figure is better than the finding in Ghanaian study
with median survival of 90 days and only 45% of patients
reaching their 90th day after starting dialysis [11]. How-
ever, only 42.1% of the patients lived longer than one
year after dialysis initiation. The 5 year survival rate was
14.8%. When compared with the long term survival in
developed countries where the 2-, 5- and 10-year survival
was 67, 35 and 11% respectively [14], this finding is negli-
gible. These results pose a question on the adequacy of
dialysis delivery in the country. However, other factors
should be also considered and be addressed in future pro-
spective studies.
Multivariate analysis did not show the influence of
socio-demographic factors and supportive cares given on
short-term and long survival. This can be explained by
the fact that survival was very low among all groups. In
addition, the small sample size in each group was not
enough to detect the difference.
Septicemia accounted for 34.1% of all the causes of mor-
tality. These were patients who had catheter as permanents for end stage renal disease in Ethiopia
ale, N (%) Female, N (%) P – value
0.915
26 (46.4) 15 (42.9)
8 (14.3) 6 (17.7)
22 (39.3) 14 (40.0)
8 (30.8) 6 (40.0)
0.886
8 (30.8) 4 (26.7)
6 (23.1) 4 (26.7)
1 (3.8) 0
3 (11.5) 1 (6.7)
country, 7 transferred to other centers in the country.
Figure 1 Kaplan – Meier survival curves in patients on dialysis in Ethiopia.
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ence of septicemia from potential catheter exit site.
The most powerful predictor of patient survival was
thus type of vascular access (p < 0.0001). Catheter as a
vascular access was associated with poor outcome as
compared to graft in Dialysis Outcomes and Practice
Patterns Study (DOPPS) [15]. Similarly, in this study,
42% of patients had catheter as vascular access and
the death toll in these groups was 96%, much higher
than the other groups. Survival at 1 year was 5.4% for
catheter group and 66.9% in other types of vascular
accesses (p < 0.0001).Although important findings were obtained from the
present study, there are some limitations worth men-
tioning. The study was based on chart revision where in-
complete documentation, inappropriate chart labeling
and lost records made it difficult to include all patients
registered for dialysis. Urea reduction ratio is the cheapest
but an invaluable parameter to assess dialysis adequacy,
however, it was inconsistently done and could not be used
in this study. Complete anthropometric measurements,
glomerular filtration rate, serum albumin and electrolyte
were rarely done and could not be used for this study. As
a result, it was difficult to state the overall clinical
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death as well. Furthermore, data was collected from one
health care center, and thus a small sample size. Most of
the patients were from the capital Addis Ababa; a region
characterized by a better socio-economic status, and
therefore, cannot be used as representative national data.
Conclusion
Dialysis as treatment modality is extremely scarce in
Ethiopia and affordable to only the rich. Its effect on
improving survival is far short of the usual standards in
the developed world and needs further investigation. We
thus recommend a large scale analysis of national dialysis
registry at all dialysis centers in the country. Furthermore,
we urge all concerned to investigate the epidemiology of
CKD in the country to plan further intervention.
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